Bionemo Framework
Vendor:
First CVE: Mar 31, 2026 · Active for under a year
4
Total CVEs
More Total CVEs than 72% of tracked products
4.0
Avg CVEs / Year
Higher CVE frequency than 83% of tracked products
8.8
Avg CVSS
Higher Avg CVSS than 79% of tracked products
0.0%
KEV Rate
Bottom 1%
Trends Over Time
The number and severity of CVEs published that impact Bionemo Framework over time
Volume of CVEsAvg CVSS Base Score
First CVE
Mar 31, 2026
3 months ago
Most Recent CVE
May 20, 2026
65 days ago
CVE Severity & Scoring
Bionemo Framework4 CVEs
75%
25%
All CVEs352,231 CVEs
45%
40%
11%
HighCritical
Attack Vector
Local1 (25.0%)
Network3 (75.0%)
Unknown0 (0.0%)
Physical0 (0.0%)
Adjacent Network0 (0.0%)
Attack Complexity
Low4 (100.0%)
High0 (0.0%)
Unknown0 (0.0%)
User Interaction
None2 (50.0%)
Unknown0 (0.0%)
Required2 (50.0%)
Privileges Required
Low1 (25.0%)
High0 (0.0%)
None3 (75.0%)
Unknown0 (0.0%)
Top CVEs
Signals from CVEs in this product scope (4 CVEs).
4 CVEs · Highest risk first
| CVE | Published | CVSS | Risk | KEV | Exploit |
|---|---|---|---|---|---|
CVE-2026-24217HIGH NVIDIA BioNeMo Core for Linux contains a vulnerability where a user could cause a path traversal by loading a malicious file. A successful exploit of this vulnerability might lead | May 20, 2026 | 8.8 | 36 | NO | NO |
CVE-2026-24164CRITICAL NVIDIA BioNeMo contains a vulnerability where a user could cause a deserialization of untrusted data. A successful exploit of this vulnerability might lead to code execution, denia | Mar 31, 2026 | 9.8 | 33 | NO | NO |
CVE-2026-24216HIGH NVIDIA BioNemo for Linux contains a vulnerability where a user could cause a deserialization of untrusted data. A successful exploit of this vulnerability might lead to code execut | May 20, 2026 | 7.8 | 32 | NO | NO |
CVE-2026-24165HIGH NVIDIA BioNeMo contains a vulnerability where a user could cause a deserialization of untrusted data. A successful exploit of this vulnerability might lead to code execution, denia | Mar 31, 2026 | 8.8 | 29 | NO | NO |
Exploit Exposure
Signals from CVEs in this product scope (4 CVEs).
CISA KEV
0 CVEs
0.0% of CVEs· Bottom 1%
Metasploit
0 CVEs
0.0% of CVEs· Bottom 1%
Nuclei
0 CVEs
0.0% of CVEs· Bottom 1%
ExploitDB
0 CVEs
0.0% of CVEs· Bottom 1%
Social Chatter
Signals from CVEs in this product scope (4 CVEs).
Media Mentions
Signals from CVEs in this product scope (4 CVEs).
Top CNAs Publishing CVEs For Bionemo Framework
Top CWEs
Versions
No cataloged versions.